TJ DaRenTang (600329.SH): Currently holds a 43.35% equity stake in Tianyao Taiping Pharmaceutical Co., Ltd.

On December 26, Gelonghui reported that TJ DaRenTang (600329.SH) announced that the company will price the entire equity of its wholly-owned subsidiary Tianjin Zhongxin Pharmaceutical Co., Ltd. and inject it as a capital increase into the wholly-owned subsidiary of its controlling shareholder Tianjin Pharmaceutical Group Co., Ltd., JinYao Taiping Pharmaceutical Co., Ltd., and signed the "Capital Increase Agreement between JinYao DaRenTang Group Co., Ltd. and JinYao Taiping Pharmaceutical Co., Ltd." Recently, JinYao Taiping Pharmaceutical Co., Ltd. and Tianjin Zhongxin Pharmaceutical Co., Ltd. have completed the business change registration procedures. Therefore, this Trade has been completed, and the company holds 43.35% of JinYao Taiping Pharmaceutical Co., Ltd.

Gelonghui FinanceDec 26 15:42

Express News | TJ DaRenTang: The company's general manager, Wang Lei, has resigned.

BreakingsDec 10 16:38

Tianjin Pharmaceutical Da Ren Tang Group Appoints Chair

MT NewswiresNov 27 14:54

TJ Darentang USD: Wang Lei replaces Zhang Mingrui as the chairman, the company's development global strategy "will not change" | Speed ​​reading announcement

① Zhang Mingrui applied to resign as the chairman, director, and chairman of the global strategy committee of tj darentang usd due to work changes. ② Wang Lei, the general manager, took over as chairman, with company officials stating that the enterprise development strategy "will not change".

cls.cnNov 26 21:20

tj darentang (600329.SH): Elected director Wang Lei as the chairman of the company.

Gelonghui November 26th | tj darentang usd (600329.SH) announced that Ms. Zhang Mingrui submitted a written resignation. Due to job changes, Ms. Zhang Mingrui applied to resign from the positions of company director, director, and chairman of the board of directors. After resigning, Ms. Zhang Mingrui will no longer hold any position in the company. After the nomination and review by the board of directors' nominating committee, the meeting approved the "election of Ms. Wang Lei as the company's chairman of the board of directors." According to the company's articles of association, the company's legal representative has changed to Ms. Wang Lei.

Gelonghui FinanceNov 26 16:38

tj darentang plans to sell 13% of its stake in China and America Shire, pending antitrust review | Directly hitting the shareholder meeting.

At today's tj darentang shareholder meeting, the proposal to sell 13% equity of China-US Tianjin Shexi Pharmaceutical Co., Ltd. (referred to as China-US Shexi) to Heiliong was approved. Company chairman Zhang Mingrui said: "China-US Shexi is an excellent company, and the main reason for this equity sale is the expiration of the 40-year cooperation period." This equity sale still needs to be reviewed for anti-monopoly by the State Administration for Market Regulation on Heiliong's side.

cls.cnNov 22 19:16